Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312127249> ?p ?o ?g. }
- W4312127249 endingPage "15751" @default.
- W4312127249 startingPage "15751" @default.
- W4312127249 abstract "Triple-negative breast cancer (TNBC) is characterized by a high possibility of metastasis. M2-like tumor-associated macrophages (TAMs) are the main components of the tumor microenvironment (TME) and play a key role in TNBC metastasis. Therefore, TAMs may be a potential target for reducing TNBC metastasis. Melittin-dKLA, a peptide composed of fused melittin and pro-apoptotic peptide d(KLAKLAK)2 (dKLA), showed a potent therapeutic effect against cancers by depleting TAMs. However, melittin has a strong adverse hemolytic effect. Hence, we attempted to improve the therapeutic potential of melittin-dKLA by reducing toxicity and increasing stability. Nine truncated melittin fragments were synthesized and examined. Of the nine peptides, the melittin-dKLA8-26 showed the best binding properties to M2 macrophages and discriminated M0/M1/M2. All fragments, except melittin, lost their hemolytic effects. To increase the stability of the peptide, melittin-dKLA8-26 fragment was conjugated with PEGylation at the amino terminus and was named PEG-melittin-dKLA8-26. This final drug candidate was assessed in vivo in a murine TNBC model and showed superior effects on tumor growth, survival rates, and lung metastasis compared with the previously used melittin-dKLA. Taken together, our study showed that the novel PEG-melittin-dKLA8-26 possesses potential as a new drug for treating TNBC and TNBC-mediated metastasis by targeting TAMs." @default.
- W4312127249 created "2023-01-04" @default.
- W4312127249 creator A5006458589 @default.
- W4312127249 creator A5016162367 @default.
- W4312127249 creator A5054619950 @default.
- W4312127249 creator A5078438975 @default.
- W4312127249 date "2022-12-12" @default.
- W4312127249 modified "2023-10-01" @default.
- W4312127249 title "Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer" @default.
- W4312127249 cites W1582289324 @default.
- W4312127249 cites W1587050401 @default.
- W4312127249 cites W1839516892 @default.
- W4312127249 cites W1843302206 @default.
- W4312127249 cites W1972769300 @default.
- W4312127249 cites W1972825083 @default.
- W4312127249 cites W1974134824 @default.
- W4312127249 cites W2000427806 @default.
- W4312127249 cites W2016869568 @default.
- W4312127249 cites W2022234371 @default.
- W4312127249 cites W2028376975 @default.
- W4312127249 cites W2031213053 @default.
- W4312127249 cites W2044897724 @default.
- W4312127249 cites W2055436838 @default.
- W4312127249 cites W2058648826 @default.
- W4312127249 cites W2063195096 @default.
- W4312127249 cites W2063808705 @default.
- W4312127249 cites W2065876461 @default.
- W4312127249 cites W2081915365 @default.
- W4312127249 cites W2100969613 @default.
- W4312127249 cites W2111021036 @default.
- W4312127249 cites W2144796447 @default.
- W4312127249 cites W2166770130 @default.
- W4312127249 cites W2168587151 @default.
- W4312127249 cites W2173733507 @default.
- W4312127249 cites W2261120022 @default.
- W4312127249 cites W2291150896 @default.
- W4312127249 cites W2614874910 @default.
- W4312127249 cites W2729672742 @default.
- W4312127249 cites W2791551019 @default.
- W4312127249 cites W2794485348 @default.
- W4312127249 cites W2797866384 @default.
- W4312127249 cites W2808045598 @default.
- W4312127249 cites W2885957766 @default.
- W4312127249 cites W2889189861 @default.
- W4312127249 cites W2892206109 @default.
- W4312127249 cites W2902586760 @default.
- W4312127249 cites W2921622709 @default.
- W4312127249 cites W2948475148 @default.
- W4312127249 cites W2956024695 @default.
- W4312127249 cites W2963568636 @default.
- W4312127249 cites W2964173709 @default.
- W4312127249 cites W2980823965 @default.
- W4312127249 cites W2980863204 @default.
- W4312127249 cites W2982501627 @default.
- W4312127249 cites W3005410912 @default.
- W4312127249 cites W3016420812 @default.
- W4312127249 cites W3027667808 @default.
- W4312127249 cites W3033869790 @default.
- W4312127249 cites W3084515187 @default.
- W4312127249 cites W3093085805 @default.
- W4312127249 cites W3093826348 @default.
- W4312127249 cites W3095082298 @default.
- W4312127249 cites W3109853980 @default.
- W4312127249 cites W3123634152 @default.
- W4312127249 cites W3130791700 @default.
- W4312127249 cites W3136116750 @default.
- W4312127249 cites W3148546123 @default.
- W4312127249 cites W3162236893 @default.
- W4312127249 cites W3162733120 @default.
- W4312127249 cites W3163056421 @default.
- W4312127249 cites W3164563452 @default.
- W4312127249 cites W3198920641 @default.
- W4312127249 cites W4212797479 @default.
- W4312127249 cites W4212959738 @default.
- W4312127249 cites W4213159182 @default.
- W4312127249 cites W4214924946 @default.
- W4312127249 cites W4221038921 @default.
- W4312127249 cites W4283023108 @default.
- W4312127249 cites W4285795272 @default.
- W4312127249 doi "https://doi.org/10.3390/ijms232415751" @default.
- W4312127249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36555393" @default.
- W4312127249 hasPublicationYear "2022" @default.
- W4312127249 type Work @default.
- W4312127249 citedByCount "3" @default.
- W4312127249 countsByYear W43121272492023 @default.
- W4312127249 crossrefType "journal-article" @default.
- W4312127249 hasAuthorship W4312127249A5006458589 @default.
- W4312127249 hasAuthorship W4312127249A5016162367 @default.
- W4312127249 hasAuthorship W4312127249A5054619950 @default.
- W4312127249 hasAuthorship W4312127249A5078438975 @default.
- W4312127249 hasBestOaLocation W43121272491 @default.
- W4312127249 hasConcept C121608353 @default.
- W4312127249 hasConcept C126322002 @default.
- W4312127249 hasConcept C150903083 @default.
- W4312127249 hasConcept C185592680 @default.
- W4312127249 hasConcept C207001950 @default.
- W4312127249 hasConcept C2778001312 @default.
- W4312127249 hasConcept C2779013556 @default.